The Global Bacterial Vaccines Market Growth Accelerated By Growing Healthcare Infrastructure
Bacterial vaccines are intended to protect individuals against bacterial infections caused by pathogens like diphtheria, pertussis, tetanus, pneumococcal disease, meningococcal disease, and Haemophilus influenzae type b. The growing prevalence of these bacterial diseases is augmenting the demand for bacterial vaccines globally. Moreover, rising healthcare infrastructure development and increasing government initiatives to spread awareness about vaccination are propelling the global bacterial vaccines market growth.
The global Bacterial Vaccines Market is estimated to be valued at US$
27.39 Mn in 2023 and is expected to
exhibit a CAGR of 6.9% over the forecast period 2024 to 2031, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends fueling the bacterial vaccines market growth is the
increasing adoption of multivalent bacterial vaccine products. Multivalent
vaccines target multiple bacterial strains in a single vaccination and provide
broader protection against related pathogens. They help minimize the number of
required vaccination doses and simplify the vaccination schedule. This drives
their preference over monovalent vaccines. Continuous research activities to
develop multivalent vaccines for various diseases like meningococcal disease,
diphtheria-tetanus-pertussis, and pneumococcal disease are expected to support
the market growth over the forecast period. Advancements in conjugate vaccine
technology used for developing multivalent bacterial vaccines have transformed
the prophylactic market in recent years.
Segment Analysis
The global bacterial vaccines market is dominated by the monovalent bacterial
vaccines segment. This is because the majority of medical conditions vaccinated
using bacterial vaccines require only vaccination against a single pathogen,
making monovalent vaccines sufficient. Some of the diseases for which
monovalent vaccines are effective include tetanus, diphtheria, and pertussis.
Key Takeaways
The global Bacterial
Vaccines Market Demand is expected to witness high growth over the
forecast period of 2024 to 2031. The global bacterial vaccines market is
estimated to be valued at US$ 27.39 Mn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.
North America currently has the largest share in the global bacterial vaccines
market primarily due to advanced healthcare facilities and widespread awareness
about the benefits of vaccination. However, over the forecast period, Asia
Pacific is anticipated to be the fastest growing regional market due to
improving healthcare infrastructure and rising disposable incomes in countries
such as China and India. Government initiatives and programs aimed at
immunizing populations against communicable diseases will further aid market
growth in Asia Pacific.
Key players operating in the bacterial vaccines market include Mondi Group,
Kuraray Co. Ltd., Cortec Corporation, Arrow GreenTech Ltd., AMC (UK) Ltd.,
Aicello Corporation, Sekisui Chemical Co. Ltd., Neptun Technologies GmbH, and
Mitsubishi Chemical Corporation, among others. Mondi Group holds a significant
share of the market owing to its robust portfolio of monovalent and multivalent
bacterial vaccines to immunize against various communicable diseases.
Explore more
related article on this topic: https://www.newsstatix.com/bacterial-vaccines-market-growth-analysis/
For More Insights On
This Topic: https://captionssky.com/adhesive-tapes-evolution-and-applications/

Comments
Post a Comment